Trifluoperazine
- Generic Name
- Trifluoperazine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H24F3N3S
- CAS Number
- 117-89-5
- Unique Ingredient Identifier
- 214IZI85K3
- Background
A phenothiazine with actions similar to chlorpromazine. It is used as an antipsychotic and an antiemetic.
- Indication
For the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation.
- Associated Conditions
- Agitation, Psychosis, Schizophrenia, Acute non-psychotic Anxiety
- Associated Therapies
- -
The Use of Trifluoperazine in Transfusion Dependent DBA
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2019-05-29
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Adrianna Vlachos, MD
- Target Recruit Count
- 2
- Registration Number
- NCT03966053
- Locations
- 🇺🇸
The Feinstein Institute for Medical Research, Manhasset, New York, United States
🇺🇸Boston Children's hospital, Boston, Massachusetts, United States
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Completed
- Conditions
- Interventions
- Other: Caregiver psycho-education and skills trainingOther: Caregiver support available at the study siteDrug: Paliperidone palmitateDrug: ChlorpromazineDrug: DroperidolDrug: FluphenazineDrug: HaloperidolDrug: LoxapineDrug: PerphenazineDrug: PimozideDrug: ProchlorperazineDrug: ThiothixeneDrug: ThioridazineDrug: TrifluoperazineDrug: AripiprazoleDrug: AsenapineDrug: ClozapineDrug: IloperidoneDrug: OlanzapineDrug: PaliperidoneDrug: QuetiapineDrug: RisperidoneDrug: Ziprasidone
- First Posted Date
- 2015-11-09
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Janssen Scientific Affairs, LLC
- Target Recruit Count
- 296
- Registration Number
- NCT02600741
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath